Fox Chase Cancer Center News

PHILADELPHIA (April 3, 2024) — It is official! The fundraising period has kicked off for Fox Chase Cancer Center’s Paws for the Cause 2024, presented by the Board of Associates. Supporters came together at a special tea in March to introduce this year’s event ambassadors and to sign up participants for this beloved dog walk, set for Sunday, September 15, 2024.

PHILADELPHIA (March 28, 2024) — Fox Chase Cancer Center is proud to welcome patients to its newly opened office, which is located at 502 Centennial Boulevard, Suite 7, in Voorhees, New Jersey. The site, which is the first that Fox Chase has opened in New Jersey, welcomes patients from within the region and beyond for treatment for urologic oncology, benign urologic conditions, plastic and reconstructive surgery, and radiation oncology consults. (Pictured Alexander Kutikov, MD, FACS, Chair and Professor, Department of Urology and Roberta R. Scheller Chair in Urologic Oncology)

PHILADELPHIA (March 27, 2024) — Over the past year, the Fox Chase Cancer Center Radiation Oncology team led by Eric Horwitz, MD, FABS, FASTRO, Chair of the Department of Radiation Oncology at Fox Chase and the Lewis Katz School of Medicine at Temple University, has boldly moved adaptive radiation therapy into the mainstream, demonstrating its clinical advantages for treating prostate, bladder, liver, pancreas, breast, lung, and head and neck cancers. Horwitz says, “We have built Fox Chase into a national and regional leader offering a robust clinical care program, innovative clinical trials, and the experience of treating many patients.”

PHILADELPHIA (March 22, 2024) – Fox Chase Cancer Center and Temple University Hospital – Main Campus have been recognized by the QOPI Certification Program LLC as successfully completing a three-year recertification for outpatient hematology-oncology practices that meet nationally recognized standards for quality cancer care. The QOPI program is a wholly owned subsidiary of the Association for Clinical Oncology and an affiliate of the American Society of Clinical Oncology (ASCO).

PHILADELPHIA (March 20, 2024) – The journal European Urology has named Fox Chase Cancer Center urologic oncologist Andres F. Correa, MD, its March 2024 Reviewer of the Month.

PHILADELPHIA (March 18, 2024) — Judy Loc, BSN, RN, could not make it to work on January 11, 2024, the day her son, Tyler Loc, BSN, RN, received his DAISY Award at Fox Chase Cancer Center. She was home recovering from COVID-19, but she knew full well the mix of pride and appreciation of recognition that comes from receiving a DAISY Award, having won the award herself the previous January.

PHILADELPHIA (March 18, 2024) — Scientists at the Fels Cancer Institute for Personalized Medicine and the Department of Cancer and Cellular Biology at the Lewis Katz School of Medicine at Temple University and Fox Chase Cancer Center have developed a novel therapeutic strategy that attacks and destroys leukemia clones, an approach that could potentially prevent patients from relapsing after treatment.

PHILADELPHIA (March 18, 2024) – The hour was early, but the enthusiasm was great. Researchers, clinicians, and advocates from across the Philadelphia region gathered at Fox Chase Cancer Center on Thursday, March 7, 2024 at 6:30 a.m. for the 2024 PurpleStride Philadelphia Leadership Breakfast. Hosted by the Philadelphia Affiliate of the Pancreatic Cancer Action Network (PanCAN) and sponsored by Fox Chase, the event brought together champions in pancreatic cancer research and treatment for discussion and networking.